Estimated Drinking Water Fluoride Exposure and Risk of Hip Fracture: A Cohort Study

被引:14
作者
Nasman, P. [1 ,2 ,3 ]
Ekstrand, J. [3 ]
Granath, F. [1 ,2 ]
Ekbom, A. [1 ,2 ]
Fored, C. M. [1 ,2 ]
机构
[1] Karolinska Inst, Clin Epidemiol Unit, Solna, Sweden
[2] Karolinska Univ Hosp, Solna, Sweden
[3] Karolinska Inst, Dept Dent Med, Huddinge, Sweden
关键词
chronic exposure; nationwide cohort study; epidemiology; relative risk; Sweden; BONE MASS; SWEDEN; OSTEOPOROSIS; SMOKING; WOMEN;
D O I
10.1177/0022034513506443
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The cariostatic benefit from water fluoridation is indisputable, but the knowledge of possible adverse effects on bone and fracture risk due to fluoride exposure is ambiguous. The association between long-term (chronic) drinking water fluoride exposure and hip fracture (ICD-7-9: 820' and ICD-10: S72.0-S72.2') was assessed in Sweden using nationwide registers. All individuals born in Sweden between January 1, 1900 and December 31, 1919, alive and living in their municipality of birth at the time of start of follow-up, were eligible for this study. Information on the study population (n = 473,277) was linked among the Swedish National In-Patient Register (IPR), the Swedish Cause of Death Register, and the Register of Population and Population Changes. Estimated individual drinking water fluoride exposure was stratified into 4 categories: very low, < 0.3 mg/L; low, 0.3 to 0.69 mg/L; medium, 0.7 to 1.49 mg/L; and high, 1.5 mg/L. Overall, we found no association between chronic fluoride exposure and the occurrence of hip fracture. The risk estimates did not change in analyses restricted to only low-trauma osteoporotic hip fractures. Chronic fluoride exposure from drinking water does not seem to have any important effects on the risk of hip fracture, in the investigated exposure range.
引用
收藏
页码:1029 / 1034
页数:6
相关论文
共 25 条
[1]   PROSPECTIVE COMPARISON OF HIP FRACTURE TREATMENT - 856 CASES FOLLOWED FOR 4 MONTHS IN THE NETHERLANDS AND SWEDEN [J].
BERGLUNDRODEN, M ;
SWIERSTRA, BA ;
WINGSTRAND, H ;
THORNGREN, KG .
ACTA ORTHOPAEDICA SCANDINAVICA, 1994, 65 (03) :287-294
[2]  
CAULEY JA, 1995, J BONE MINER RES, V10, P1076
[3]   RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].
CUMMINGS, SR ;
NEVITT, MC ;
BROWNER, WS ;
STONE, K ;
FOX, KM ;
ENSRUD, KE ;
CAULEY, JC ;
BLACK, D ;
VOGT, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773
[4]  
EKSTRAND J, 1978, CLIN PHARMACOL THER, V23, P329
[5]   FLUORIDE PHARMACOKINETICS IN INFANCY [J].
EKSTRAND, J ;
FOMON, SJ ;
ZIEGLER, EE ;
NELSON, SE .
PEDIATRIC RESEARCH, 1994, 35 (02) :157-163
[6]   Body size and hip fracture risk [J].
Farahmand, BY ;
Michaëlsson, K ;
Baron, JA ;
Persson, PG ;
Ljunghall, S .
EPIDEMIOLOGY, 2000, 11 (02) :214-219
[7]   ERYTHROCYTE INCORPORATION OF INGESTED FE-58 BY 56-DAY-OLD BREAST-FED AND FORMULA-FED INFANTS [J].
FOMON, SJ ;
ZIEGLER, EE ;
NELSON, SE .
PEDIATRIC RESEARCH, 1993, 33 (06) :573-576
[8]   Fluoride in drinking water and risk of hip fracture in the UK: a case-control study [J].
Hillier, S ;
Cooper, C ;
Kellingray, S ;
Russell, G ;
Hughes, H ;
Coggon, D .
LANCET, 2000, 355 (9200) :265-269
[9]  
Kurttio P, 1999, AM J EPIDEMIOL, V150, P817, DOI 10.1093/oxfordjournals.aje.a010086
[10]   A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect [J].
Law, MR ;
Hackshaw, AK .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7112) :841-846